Implantable lens maker Eyeonics aims for $86M IPO
Eyeonics, an Aliso Viejo, Calif., developer of implantable lenses for cataract patients, filed to raise as much as $86.25 million in an IPO. The company makes and sells “premium intraocular lenses” that correct vision in addition to replacing a lens obscured by cataracts.
Next Story: Talecris, a ludicrously large IPO, and the beginning of the end for private equity?
Previous Story: Quark Pharma IPO collapses
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.